Tumor necrosis factor induces the production of urokinase-type plasminogen activator by human endothelial cells
- PMID: 2140060
Tumor necrosis factor induces the production of urokinase-type plasminogen activator by human endothelial cells
Abstract
Endothelial cells play an important role in the regulation of fibrinolysis by the production of several key regulatory proteins. The cytokines tumor necrosis factor (TNF), lymphotoxin, and interleukin-1 (IL-1), but not interleukin-6, increase the production of plasminogen activator inhibitor-1 (PAI-1) by endothelial cells, whereas they have no stimulatory effect on the production of tissue-type plasminogen activator (t-PA). Primary cultures of human endothelial cells release very little urokinase-type plasminogen activator (u-PA). We report here that TNF and lymphotoxin induce, in a concentration-dependent way, the production of both cellular and secreted u-PA antigen in primary and subcultured human endothelial cells. The TNF-induced increase was accompanied by a more than 10-fold increase in u-PA mRNA. Upon stimulation of early passage umbilical vein endothelial cells by TNF, u-PA was predominantly secreted at the basolateral side, whereas PAI activity and t-PA were found in more equal amounts at the apical and basolateral sides of the cell monolayers. TNF-stimulated u-PA secretion by subcultured human aorta endothelial cells showed only a marginal polarity. The u-PA antigen was present in a plasmin-activatable form (single chain u-PA) and in a nonactivatable form (probably u-PA: PAI-1 complex). During the induction of u-PA by TNF, the ratio between plasmin-activatable u-PA and total u-PA decreased markedly. This may indicate that TNF also increases the degree of u-PA activation. The parallel induction of the synthesis and secretion of both u-PA and PAI-1 by endothelial cells adds a new aspect to the alterations of the fibrinolytic system caused by inflammatory mediators. This aspect may be significant for the regulation of cell-associated and interstitial plasminogen activator activity.
Similar articles
-
Tumor necrosis factor increases the production of plasminogen activator inhibitor in human endothelial cells in vitro and in rats in vivo.Blood. 1988 Nov;72(5):1467-73. Blood. 1988. PMID: 3140909
-
Interferon-gamma modulates the fibrinolytic response in cultured human endothelial cells.Thromb Res. 1995 Mar 1;77(5):431-40. doi: 10.1016/0049-3848(95)93879-5. Thromb Res. 1995. PMID: 7778058
-
Tumor necrosis factor-alpha regulates mRNA for urokinase-type plasminogen activator and type-1 plasminogen activator inhibitor in human neoplastic cell lines.Mol Cell Endocrinol. 1989 Jan;61(1):87-96. doi: 10.1016/0303-7207(89)90192-5. Mol Cell Endocrinol. 1989. PMID: 2501120
-
Cytokine regulation of endothelial cell extracellular proteolysis.Agents Actions Suppl. 1993;42:179-93. doi: 10.1007/978-3-0348-7397-0_15. Agents Actions Suppl. 1993. PMID: 8356923 Review.
-
Regulation of the synthesis and secretion of plasminogen activators by endothelial cells.Haemostasis. 1988;18(4-6):307-27. doi: 10.1159/000215814. Haemostasis. 1988. PMID: 3148525 Review.
Cited by
-
c-ets1 proto-oncogene is a transcription factor expressed in endothelial cells during tumor vascularization and other forms of angiogenesis in humans.Am J Pathol. 1992 Jan;140(1):119-27. Am J Pathol. 1992. PMID: 1370594 Free PMC article.
-
Endothelium--role in regulation of coagulation and inflammation.Semin Immunopathol. 2012 Jan;34(1):93-106. doi: 10.1007/s00281-011-0285-5. Epub 2011 Aug 4. Semin Immunopathol. 2012. PMID: 21845431 Free PMC article. Review.
-
Fibrinolytic mechanisms in tumor growth and spreading.Clin Investig. 1992 Aug;70(8):631-6. doi: 10.1007/BF00180278. Clin Investig. 1992. PMID: 1392438 Review.
-
Atheromatous plaque macrophages produce plasminogen activator inhibitor type-1 and stimulate its production by endothelial cells and vascular smooth muscle cells.Am J Pathol. 1993 Sep;143(3):875-85. Am J Pathol. 1993. PMID: 8362983 Free PMC article.
-
Impaired fibrinolysis in the hemolytic-uremic syndrome of childhood.Ann Hematol. 1994 Jan;68(1):43-8. doi: 10.1007/BF01695919. Ann Hematol. 1994. PMID: 8110878
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous